Daniel A. Donahue

1.7k total citations
25 papers, 1.3k citations indexed

About

Daniel A. Donahue is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Daniel A. Donahue has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Virology, 11 papers in Immunology and 8 papers in Infectious Diseases. Recurrent topics in Daniel A. Donahue's work include HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (7 papers) and Immune Cell Function and Interaction (7 papers). Daniel A. Donahue is often cited by papers focused on HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (7 papers) and Immune Cell Function and Interaction (7 papers). Daniel A. Donahue collaborates with scholars based in Canada, United States and France. Daniel A. Donahue's co-authors include Mark A. Wainberg, Richard D. Sloan, Björn D. Kuhl, Tamara Bar-Magen, Michael P. Manns, Herbert L. Bonkovsky, Edward Cable, Olivier Schwartz, Nicoletta Casartelli and Hongtao Xu and has published in prestigious journals such as Science, Nature Communications and PLoS ONE.

In The Last Decade

Daniel A. Donahue

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel A. Donahue Canada 18 745 486 404 327 317 25 1.3k
Peter K. Cheung Canada 17 638 0.9× 567 1.2× 254 0.6× 359 1.1× 369 1.2× 29 1.3k
Isabella Abbate Italy 22 694 0.9× 506 1.0× 363 0.9× 449 1.4× 260 0.8× 87 1.4k
Montserrat Plana Spain 21 1.1k 1.5× 835 1.7× 631 1.6× 298 0.9× 218 0.7× 60 1.7k
Doreen B. Brettler United States 21 1.3k 1.7× 801 1.6× 638 1.6× 496 1.5× 276 0.9× 43 2.4k
Debbie van Baarle Netherlands 21 304 0.4× 302 0.6× 644 1.6× 541 1.7× 180 0.6× 47 1.3k
Eric G. Meissner United States 21 266 0.4× 225 0.5× 283 0.7× 629 1.9× 216 0.7× 69 1.3k
Rosemary Ffrench Australia 20 300 0.4× 198 0.4× 488 1.2× 748 2.3× 184 0.6× 43 1.5k
Thomas Kuntzen United States 18 385 0.5× 182 0.4× 431 1.1× 479 1.5× 153 0.5× 37 1.2k
Anne Edwards United Kingdom 12 1.2k 1.6× 401 0.8× 1.2k 3.0× 321 1.0× 277 0.9× 17 1.7k
Emmanouil Papasavvas United States 22 987 1.3× 528 1.1× 870 2.2× 318 1.0× 190 0.6× 46 1.7k

Countries citing papers authored by Daniel A. Donahue

Since Specialization
Citations

This map shows the geographic impact of Daniel A. Donahue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Donahue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Donahue more than expected).

Fields of papers citing papers by Daniel A. Donahue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Donahue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Donahue. The network helps show where Daniel A. Donahue may publish in the future.

Co-authorship network of co-authors of Daniel A. Donahue

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Donahue. A scholar is included among the top collaborators of Daniel A. Donahue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Donahue. Daniel A. Donahue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Persaud, Mirjana, Anastasia Selyutina, Cindy Buffone, et al.. (2021). Nuclear restriction of HIV-1 infection by SUN1. Scientific Reports. 11(1). 19128–19128. 2 indexed citations
2.
Buchrieser, Julian, Séverine A. Degrelle, Thérèse Couderc, et al.. (2019). IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise. Science. 365(6449). 176–180. 107 indexed citations
3.
Donahue, Daniel A., et al.. (2017). SUN2 Silencing Impairs CD4 T Cell Proliferation and Alters Sensitivity to HIV-1 Infection Independently of Cyclophilin A. Journal of Virology. 91(6). 24 indexed citations
4.
Bruel, Timothée, Florence Guivel‐Benhassine, Sonia Amraoui, et al.. (2016). Elimination of HIV-1-infected cells by broadly neutralizing antibodies. Nature Communications. 7(1). 10844–10844. 187 indexed citations
5.
Donahue, Daniel A., Sonia Amraoui, Francesca Di Nunzio, et al.. (2016). SUN2 Overexpression Deforms Nuclear Shape and Inhibits HIV. Journal of Virology. 90(8). 4199–4214. 39 indexed citations
6.
7.
Donahue, Daniel A. & Mark A. Wainberg. (2013). Cellular and molecular mechanisms involved in the establishment of HIV-1 latency. Retrovirology. 10(1). 11–11. 90 indexed citations
10.
Sloan, Richard D., Björn D. Kuhl, Thibault Mésplède, et al.. (2013). Productive Entry of HIV-1 during Cell-to-Cell Transmission via Dynamin-Dependent Endocytosis. Journal of Virology. 87(14). 8110–8123. 51 indexed citations
11.
Kramer, Victor G., Susan M. Schader, Maureen Oliveira, et al.. (2012). Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-Specific Redistribution Effect That Results in Increased Extracellular Viral Load. Antimicrobial Agents and Chemotherapy. 56(8). 4154–4160. 23 indexed citations
12.
Donahue, Daniel A., Björn D. Kuhl, Richard D. Sloan, & Mark A. Wainberg. (2012). The Viral Protein Tat Can Inhibit the Establishment of HIV-1 Latency. Journal of Virology. 86(6). 3253–3263. 58 indexed citations
13.
Kuhl, Björn D., Daniel A. Donahue, Richard D. Sloan, et al.. (2011). The HIV-1 Vpu Viroporin Inhibitor BIT225 Does Not Affect Vpu-Mediated Tetherin Antagonism. PLoS ONE. 6(11). e27660–e27660. 20 indexed citations
14.
Kuhl, Björn D., Richard D. Sloan, Daniel A. Donahue, Chen Liang, & Mark A. Wainberg. (2011). Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4+ T-cells is not directly related to the extent of tetherin cell surface downmodulation. Virology. 417(2). 353–361. 7 indexed citations
15.
Sloan, Richard D., et al.. (2011). Transcription of Preintegrated HIV-1 cDNA Modulates Cell Surface Expression of Major Histocompatibility Complex Class I via Nef. Journal of Virology. 85(6). 2828–2836. 14 indexed citations
16.
Kuhl, Björn D., Richard D. Sloan, Daniel A. Donahue, et al.. (2010). Tetherin restricts direct cell-to-cell infection of HIV-1. Retrovirology. 7(1). 115–115. 82 indexed citations
17.
Bar-Magen, Tamara, Daniel A. Donahue, Björn D. Kuhl, et al.. (2010). HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays. AIDS. 24(14). 2171–2179. 52 indexed citations
18.
Sloan, Richard D., Daniel A. Donahue, Björn D. Kuhl, Tamara Bar-Magen, & Mark A. Wainberg. (2010). Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes. Retrovirology. 7(1). 44–44. 31 indexed citations
19.
Bar-Magen, Tamara, Richard D. Sloan, Daniel A. Donahue, et al.. (2009). Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes. Retrovirology. 6(1). 103–103. 40 indexed citations
20.
Donahue, Daniel A. & Farhad Navab. (1997). Significance of Short-Segment Barrett's Esophagus. Journal of Clinical Gastroenterology. 25(2). 480–484. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026